Annexon, Inc. (ANNX)

Latest Insider Confidence Score

2026Q1

51.8
Bullish

Company insider confidence (by quarter)

2020Q3 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Satter Muneer A Director 9,728,637 Nov 21, 2025
Bain Capital Life Sciences Investors, LLC 10% Owner 5,401,926 May 30, 2023
Bain Capital Life Sciences Partners, LP 10% Owner 5,401,926 May 30, 2023
BCIP Life Sciences Associates, LP 10% Owner 5,401,926 May 30, 2023
Bain Capital Life Sciences Fund, L.P. 10% Owner 5,401,926 May 30, 2023

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 2, 2026 Mar 4, 2026 Dananberg Jamie CHIEF MEDICAL OFFICER Sell 46.3 -5,820 -4.50% ✗ $31.6K
Mar 2, 2026 Mar 4, 2026 Overdorf Michael EVP & CHIEF BUSINESS OFFICER Sell 46.3 -4,339 -2.32% ✗ $23.5K
Mar 2, 2026 Mar 4, 2026 Yednock Ted EVP & CHIEF INNOVATION OFFICER Sell 46.3 -5,566 -3.48% ✗ $30.2K
Mar 2, 2026 Mar 4, 2026 ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER Sell 46.3 -5,894 -3.17% ✗ $32K
Mar 2, 2026 Mar 4, 2026 Lew Jennifer CFO Sell 46.3 -5,565 -3.16% ✗ $30.2K
Feb 19, 2026 Feb 23, 2026 Love Douglas CEO Neutral 52.5 - 0.00% ✗ -
Feb 19, 2026 Feb 23, 2026 Dananberg Jamie CHIEF MEDICAL OFFICER Neutral 90.0 +56,250 76.89% ✗ -
Feb 19, 2026 Feb 23, 2026 Overdorf Michael EVP & CHIEF BUSINESS OFFICER Neutral 90.0 +62,500 50.22% ✗ -
Feb 19, 2026 Feb 23, 2026 ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER Neutral 90.0 +62,500 50.61% ✗ -
Feb 19, 2026 Feb 23, 2026 Yednock Ted EVP & CHIEF INNOVATION OFFICER Neutral 90.0 +62,500 64.28% ✗ -
Feb 19, 2026 Feb 23, 2026 Lew Jennifer CFO Neutral 90.0 +62,500 54.94% ✗ -
Feb 18, 2026 Feb 20, 2026 Dananberg Jamie CHIEF MEDICAL OFFICER Sell 46.3 -5,290 -6.74% ✗ $27K
Feb 18, 2026 Feb 20, 2026 Lew Jennifer CFO Sell 46.3 -7,851 -6.46% ✗ $40.1K
Feb 18, 2026 Feb 20, 2026 ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER Sell 46.3 -5,290 -4.11% ✗ $27K
Feb 18, 2026 Feb 20, 2026 Yednock Ted EVP & CHIEF INNOVATION OFFICER Sell 46.3 -7,857 -7.48% ✗ $40.1K
Feb 18, 2026 Feb 20, 2026 Overdorf Michael EVP & CHIEF BUSINESS OFFICER Sell 46.3 -6,225 -4.76% ✗ $31.7K
Dec 30, 2025 Jan 2, 2026 Carson William H. Director Buy 86.3 +4,115 8.18% ✓ $20.7K
Dec 1, 2025 Dec 3, 2025 Choi Jung Director Buy 95.0 +33,000 100.00% ✗ $138.3K
Dec 1, 2025 Dec 3, 2025 Carson William H. Director Buy 86.3 +4,115 8.91% ✓ $18.4K
Nov 20, 2025 Nov 21, 2025 Satter Muneer A Director Buy 95.0 +822,613 9.24% ✗ $3.6M
Nov 17, 2025 Nov 19, 2025 Satter Muneer A Director Buy 100.0 +1,500,000 20.25% ✗ $5.1M
Oct 30, 2025 Oct 31, 2025 Carson William H. Director Buy 86.3 +4,115 9.78% ✓ $13K
Sep 30, 2025 Oct 2, 2025 Carson William H. Director Buy 91.3 +4,115 10.84% ✓ $12.6K
Sep 2, 2025 Sep 4, 2025 Carson William H. Director Buy 90.0 +4,115 12.16% ✓ $8.6K
Jul 30, 2025 Aug 1, 2025 Carson William H. Director Buy 90.0 +4,115 13.85% ✓ $10K
Jul 14, 2025 Jul 16, 2025 Yednock Ted EVP & CHIEF INNOVATION OFFICER Sell 47.5 -1,116 -1.05% ✗ $2.9K
Jul 14, 2025 Jul 16, 2025 Lew Jennifer CFO Sell 50.0 -1,117 -0.91% ✗ $2.9K
Jul 14, 2025 Jul 16, 2025 Overdorf Michael EVP & CHIEF BUSINESS OFFICER Sell 50.0 -853 -0.65% ✗ $2.2K
Jun 30, 2025 Jul 1, 2025 Carson William H. Director Buy 91.3 +4,115 16.07% ✓ $10.1K
Jun 5, 2025 Jun 9, 2025 WIGGANS THOMAS G Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 9, 2025 Satter Muneer A Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 9, 2025 Waddill William D. Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 9, 2025 Carson William H. Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 9, 2025 Choi Jung Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 9, 2025 JONES WILLIAM A JR Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 9, 2025 Cockroft Bettina M. Director Neutral 52.5 - 0.00% ✗ -
Feb 27, 2024 Mar 3, 2025 ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER Neutral 90.0 +44,963 53.65% ✗ -
Feb 27, 2024 Mar 3, 2025 Dananberg Jamie CHIEF MEDICAL OFFICER Neutral 90.0 +44,963 134.30% ✗ -
Feb 27, 2024 Mar 3, 2025 Lew Jennifer CFO Neutral 90.0 +44,963 57.82% ✗ -
Feb 27, 2025 Mar 3, 2025 Love Douglas CEO Neutral 52.5 - 0.00% ✗ -
Feb 27, 2024 Mar 3, 2025 Yednock Ted EVP & CHIEF INNOVATION OFFICER Neutral 90.0 +44,963 73.42% ✗ -
Feb 27, 2024 Mar 3, 2025 Overdorf Michael EVP & CHIEF BUSINESS OFFICER Neutral 90.0 +44,963 51.93% ✗ -
Feb 18, 2025 Feb 20, 2025 Dananberg Jamie CHIEF MEDICAL OFFICER Sell 46.3 -5,521 -14.16% ✗ $16.3K
Feb 18, 2025 Feb 20, 2025 ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER Sell 46.3 -5,515 -6.17% ✗ $16.4K
Feb 18, 2025 Feb 20, 2025 Yednock Ted EVP & CHIEF INNOVATION OFFICER Sell 46.3 -8,345 -11.99% ✗ $24.3K
Feb 18, 2025 Feb 20, 2025 Overdorf Michael EVP & CHIEF BUSINESS OFFICER Sell 46.3 -6,618 -7.10% ✗ $19.5K
Feb 18, 2025 Feb 20, 2025 Lew Jennifer CFO Sell 46.3 -6,912 -8.16% ✗ $20.2K
Feb 13, 2025 Feb 18, 2025 Love Douglas CEO Sell 46.3 -5,021 -1.41% ✗ $14.8K
Feb 13, 2025 Feb 18, 2025 Overdorf Michael EVP & CHIEF BUSINESS OFFICER Sell 47.5 -1,425 -1.51% ✗ $4.3K
Feb 13, 2025 Feb 18, 2025 Lew Jennifer CFO Sell 47.5 -1,786 -2.07% ✗ $5.3K
Feb 13, 2025 Feb 18, 2025 Yednock Ted EVP & CHIEF INNOVATION OFFICER Sell 47.5 -1,783 -2.50% ✗ $5.3K
Jan 9, 2025 Jan 10, 2025 JONES WILLIAM A JR Director Neutral 52.5 - 0.00% ✗ -
Jan 10, 2025 JONES WILLIAM A JR Director Neutral 52.5 - 0.00% ✗ -
Jan 6, 2025 Jan 8, 2025 Love Douglas CEO Neutral 52.5 - 0.00% ✗ -
Dec 2, 2024 Dec 4, 2024 Carson William H. Director Buy 91.3 +3,200 14.29% ✓ $17.1K
Oct 30, 2024 Nov 1, 2024 Love Douglas CEO Neutral 52.5 - 0.00% ✗ -
Oct 15, 2024 Oct 17, 2024 Yednock Ted EVP & CHIEF INNOVATION OFFICER Sell 36.3 -5,408 -7.04% ✓ $40.1K
Oct 1, 2024 Oct 2, 2024 Carson William H. Director Buy 91.3 +3,200 16.67% ✓ $19.1K
Sep 19, 2024 Sep 20, 2024 Yednock Ted EVP & CHIEF INNOVATION OFFICER Sell 36.3 -4,500 -5.93% ✓ $32K
Sep 12, 2024 Sep 16, 2024 Yednock Ted EVP & CHIEF INNOVATION OFFICER Sell 36.3 -5,500 -6.76% ✓ $33.9K
Sep 5, 2024 Sep 6, 2024 Yednock Ted EVP & CHIEF INNOVATION OFFICER Sell 36.3 -5,500 -6.33% ✓ $31K
Sep 3, 2024 Sep 4, 2024 Carson William H. Director Buy 91.3 +3,200 20.00% ✓ $17.5K
Aug 29, 2024 Aug 30, 2024 Yednock Ted EVP & CHIEF INNOVATION OFFICER Sell 36.3 -5,500 -5.95% ✓ $32.7K
Aug 1, 2024 Aug 5, 2024 Carson William H. Director Buy 91.3 +3,200 25.00% ✓ $20K
Jul 15, 2024 Jul 17, 2024 Overdorf Michael EVP & CHIEF BUSINESS OFFICER Sell 50.0 -784 -0.82% ✗ $4.7K
Jul 15, 2024 Jul 17, 2024 Lew Jennifer CFO Sell 47.5 -1,104 -1.26% ✗ $6.7K
Jul 15, 2024 Jul 17, 2024 Yednock Ted EVP & CHIEF INNOVATION OFFICER Sell 47.5 -1,106 -1.18% ✗ $6.7K
Jul 1, 2024 Jul 2, 2024 Carson William H. Director Buy 91.3 +3,200 33.33% ✓ $16K
Jun 5, 2024 Jun 7, 2024 WIGGANS THOMAS G Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2024 Jun 7, 2024 Satter Muneer A Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2024 Jun 7, 2024 Choi Jung Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2024 Jun 7, 2024 Waddill William D. Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2024 Jun 7, 2024 Carson William H. Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2024 Jun 7, 2024 Cockroft Bettina M. Director Neutral 52.5 - 0.00% ✗ -
Jun 3, 2024 Jun 5, 2024 Carson William H. Director Buy 91.3 +3,200 50.00% ✓ $15.5K
May 1, 2024 May 3, 2024 Carson William H. Director Buy 91.3 +3,200 100.00% ✓ $15K
Apr 8, 2024 Apr 10, 2024 Carson William H. Director Buy 91.3 +3,200 100.00% ✓ $19.4K
Feb 16, 2024 Feb 21, 2024 Love Douglas CEO Neutral 52.5 - 0.00% ✗ -
Feb 16, 2024 Feb 21, 2024 Dananberg Jamie CHIEF MEDICAL OFFICER Neutral 90.0 +39,000 100.00% ✗ -
Feb 16, 2024 Feb 21, 2024 ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER Neutral 90.0 +39,000 77.49% ✗ -
Feb 16, 2024 Feb 21, 2024 Lew Jennifer CFO Sell 91.3 +36,407 79.75% ✗ $14.3K
Feb 16, 2024 Feb 21, 2024 Yednock Ted EVP & CHIEF INNOVATION OFFICER Sell 91.3 +36,396 63.77% ✗ $14.3K
Feb 16, 2024 Feb 21, 2024 Overdorf Michael EVP & CHIEF BUSINESS OFFICER Sell 91.3 +37,049 76.25% ✗ $10.7K
Feb 12, 2024 Feb 14, 2024 Overdorf Michael EVP & CHIEF BUSINESS OFFICER Sell 47.5 -1,349 -2.70% ✗ $7.5K
Feb 12, 2024 Feb 14, 2024 Love Douglas CEO Sell 46.3 -5,782 -2.86% ✗ $32K
Feb 12, 2024 Feb 14, 2024 Lew Jennifer CFO Sell 46.3 -1,809 -3.81% ✗ $10K
Feb 12, 2024 Feb 14, 2024 Yednock Ted EVP & CHIEF INNOVATION OFFICER Sell 46.3 -1,810 -3.07% ✗ $10K
Jul 11, 2023 Jan 23, 2024 Yednock Ted EVP & Chief Innovation Officer Sell 20.0 -22,057 -18.56% ✓ $99K
Jul 11, 2023 Jan 23, 2024 Overdorf Michael EVP & Chief Business Officer Sell 47.5 -978 -2.09% ✗ $3.8K
Jul 11, 2023 Jan 23, 2024 Lew Jennifer CFO Sell 47.5 -1,057 -2.18% ✗ $4.1K
Dec 27, 2023 Dec 29, 2023 Yednock Ted EVP & Chief Innovation Officer Sell 10.0 -21,000 -100.00% ✓ $95K
Dec 26, 2023 Dec 28, 2023 Satter Muneer A Director Buy 92.5 +350,000 4.96% ✗ $1M
Aug 1, 2023 Aug 2, 2023 Dananberg Jamie Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Aug 2, 2023 Dananberg Jamie Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jun 8, 2023 Jun 12, 2023 Satter Muneer A Director Neutral 52.5 - 0.00% ✗ -
Jun 8, 2023 Jun 12, 2023 WIGGANS THOMAS G Director Neutral 52.5 - 0.00% ✗ -
Jun 8, 2023 Jun 12, 2023 Choi Jung Director Neutral 52.5 - 0.00% ✗ -
Jun 8, 2023 Jun 12, 2023 Cockroft Bettina M. Director Neutral 52.5 - 0.00% ✗ -
Jun 8, 2023 Jun 12, 2023 Waddill William D. Director Neutral 52.5 - 0.00% ✗ -
Jun 8, 2023 Jun 12, 2023 Carson William H. Director Neutral 52.5 - 0.00% ✗ -